MEDIWOUND LTD (MDWD) Fundamental Analysis & Valuation

NASDAQ:MDWD • IL0011316309

17.31 USD
-0.06 (-0.35%)
Last: Mar 11, 2026, 12:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MDWD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

MDWD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. MDWD may be in some trouble as it scores bad on both profitability and health. MDWD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. MDWD Profitability Analysis

1.1 Basic Checks

  • In the past year MDWD has reported negative net income.
  • In the past year MDWD has reported a negative cash flow from operations.
  • In the past 5 years MDWD always reported negative net income.
  • MDWD had a negative operating cash flow in each of the past 5 years.
MDWD Yearly Net Income VS EBIT VS OCF VS FCFMDWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • MDWD's Return On Assets of -21.82% is in line compared to the rest of the industry. MDWD outperforms 59.59% of its industry peers.
  • MDWD's Return On Equity of -41.08% is in line compared to the rest of the industry. MDWD outperforms 56.48% of its industry peers.
Industry RankSector Rank
ROA -21.82%
ROE -41.08%
ROIC N/A
ROA(3y)-30.14%
ROA(5y)-37.73%
ROE(3y)-99.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDWD Yearly ROA, ROE, ROICMDWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • MDWD has a Gross Margin (18.53%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of MDWD has declined.
  • The Profit Margin and Operating Margin are not available for MDWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.33%
GM growth 5Y-26.97%
MDWD Yearly Profit, Operating, Gross MarginsMDWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. MDWD Health Analysis

2.1 Basic Checks

  • MDWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MDWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MDWD Yearly Shares OutstandingMDWD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MDWD Yearly Total Debt VS Total AssetsMDWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • MDWD has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • MDWD has a Debt to Equity ratio of 0.16. This is comparable to the rest of the industry: MDWD outperforms 47.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.46%
MDWD Yearly LT Debt VS Equity VS FCFMDWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.65 indicates that MDWD has no problem at all paying its short term obligations.
  • MDWD's Current ratio of 2.65 is in line compared to the rest of the industry. MDWD outperforms 47.67% of its industry peers.
  • A Quick Ratio of 2.48 indicates that MDWD has no problem at all paying its short term obligations.
  • The Quick ratio of MDWD (2.48) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 2.48
MDWD Yearly Current Assets VS Current LiabilitesMDWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MDWD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 31.60% over the past year.
EPS 1Y (TTM)31.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-68.03%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.78% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 52.93% on average over the next years. This is a very strong growth
EPS Next Y-17.46%
EPS Next 2Y-3.18%
EPS Next 3Y2.66%
EPS Next 5Y25.78%
Revenue Next Year23.59%
Revenue Next 2Y25.01%
Revenue Next 3Y45.01%
Revenue Next 5Y52.93%

3.3 Evolution

MDWD Yearly Revenue VS EstimatesMDWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
MDWD Yearly EPS VS EstimatesMDWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. MDWD Valuation Analysis

4.1 Price/Earnings Ratio

  • MDWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDWD Price Earnings VS Forward Price EarningsMDWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDWD Per share dataMDWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.18%
EPS Next 3Y2.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDWD Dividend Analysis

5.1 Amount

  • No dividends for MDWD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDWD Fundamentals: All Metrics, Ratios and Statistics

MEDIWOUND LTD

NASDAQ:MDWD (3/11/2026, 12:59:39 PM)

17.31

-0.06 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-05
Earnings (Next)05-19
Inst Owners55.77%
Inst Owner Change7.62%
Ins Owners1.42%
Ins Owner ChangeN/A
Market Cap221.91M
Revenue(TTM)N/A
Net Income(TTM)-20.60M
Analysts83.33
Price Target32.13 (85.62%)
Short Float %13.41%
Short Ratio12.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.96%
Min EPS beat(2)-110.94%
Max EPS beat(2)71.01%
EPS beat(4)3
Avg EPS beat(4)22.9%
Min EPS beat(4)-110.94%
Max EPS beat(4)89.63%
EPS beat(8)4
Avg EPS beat(8)-27.36%
EPS beat(12)6
Avg EPS beat(12)-15.44%
EPS beat(16)7
Avg EPS beat(16)-15.08%
Revenue beat(2)0
Avg Revenue beat(2)-10.67%
Min Revenue beat(2)-19.91%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-11.79%
Min Revenue beat(4)-25.41%
Max Revenue beat(4)-0.39%
Revenue beat(8)1
Avg Revenue beat(8)-9.43%
Revenue beat(12)3
Avg Revenue beat(12)-1.65%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-22.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.6
P/FCF N/A
P/OCF N/A
P/B 4.42
P/tB 4.43
EV/EBITDA N/A
EPS(TTM)-2.1
EYN/A
EPS(NY)-2.47
Fwd EYN/A
FCF(TTM)-1.45
FCFYN/A
OCF(TTM)-1.15
OCFYN/A
SpS1.63
BVpS3.91
TBVpS3.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.82%
ROE -41.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.53%
FCFM N/A
ROA(3y)-30.14%
ROA(5y)-37.73%
ROE(3y)-99.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.33%
GM growth 5Y-26.97%
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 246.71%
Cap/Sales 18.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.65
Quick Ratio 2.48
Altman-Z N/A
F-Score4
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)321.06%
Cap/Depr(5y)217.42%
Cap/Sales(3y)22.58%
Cap/Sales(5y)14.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.56%
EPS Next Y-17.46%
EPS Next 2Y-3.18%
EPS Next 3Y2.66%
EPS Next 5Y25.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-68.03%
Revenue Next Year23.59%
Revenue Next 2Y25.01%
Revenue Next 3Y45.01%
Revenue Next 5Y52.93%
EBIT growth 1Y-37.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.07%
EBIT Next 3Y-23.24%
EBIT Next 5YN/A
FCF growth 1Y-80.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-151.78%
OCF growth 3YN/A
OCF growth 5YN/A

MEDIWOUND LTD / MDWD FAQ

What is the fundamental rating for MDWD stock?

ChartMill assigns a fundamental rating of 2 / 10 to MDWD.


What is the valuation status for MDWD stock?

ChartMill assigns a valuation rating of 0 / 10 to MEDIWOUND LTD (MDWD). This can be considered as Overvalued.


What is the profitability of MDWD stock?

MEDIWOUND LTD (MDWD) has a profitability rating of 1 / 10.